| Dr Peter Goodfield, MD | |
|
691 Blythe Street Ct, Hendersonville, NC 28739-4095 | |
| (828) 693-5010 | |
| (828) 693-7003 |
| Full Name | Dr Peter Goodfield |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 691 Blythe Street Ct, Hendersonville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043216054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 28976 (North Carolina) | Primary |
| 207R00000X | Internal Medicine | 28976 (North Carolina) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Goodfield, MD Po Box 602381, Charlotte, NC 28260-2381 Ph: (828) 693-5010 | Dr Peter Goodfield, MD 691 Blythe Street Ct, Hendersonville, NC 28739-4095 Ph: (828) 693-5010 |
News Archive
The International Osteoporosis Foundation (IOF) has released a new position statement on Vitamin D for older adults which makes important recommendations for vitamin D nutrition from an evidence-based perspective.
3000 children in Africa die every day from diseases spread through drinking contaminated water. Robin Moore, a donor and partner of The Joseph Assignment Global Initiative, is doing something about it. She has launched the 100 Day Challenge for Clean Water in Africa. She seeks donations from family, friends, and others concerned about the plight of these children to partner with The Joseph Assignment Global Initiative effort to ship two well drilling machines to Ghana, Africa, in order to effectively increase access to clean drinking water needed to save lives.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Reuters reports on a "fresh look at past research" that finds several non-medical variables may be central to how some patients do once they are discharged from the hospital.
› Verified 2 days ago
Joseph R Desantola, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 50 Hospital Dr, Suite 3b2, Hendersonville, NC 28792 Phone: 828-687-0088 Fax: 828-684-6693 | |
Dr. David F Slawek, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 510 Fleming St, Ste B, Hendersonville, NC 28739 Phone: 828-692-2801 Fax: 828-696-1756 | |
Lois Gail Clary, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 705 6th Ave W, Suite A, Hendersonville, NC 28739 Phone: 828-694-8389 | |
Martin S. Lemyre, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-694-7654 | |
Dr. Umberto Gaetano Fontana, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 709 N Justice St Ste A, Hendersonville, NC 28791 Phone: 828-697-7377 Fax: 828-697-7380 | |
Dr. Jerald D Pyles, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 705 6th Ave W, Suite A, Hendersonville, NC 28739 Phone: 828-692-2231 Fax: 828-692-9742 |